Chloroquine Recruiting Phase 2 Trials for Novel Coronavirus Infectious Disease (COVID-19) / Severe Acute Respiratory Syndrome / Severe Acute Respiratory Syndrome (SARS) Pneumonia / Clinical Trial Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT04342650Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection
NCT04328493The Vietnam Chloroquine Treatment on COVID-19
NCT04323527Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2